ULGX (ULGX) Stock Price & Analysis
ULGX (ULGX) rose 0.00% to USD 0 as of June 10, 2026 at 07:13 UTC, according to Nexqual real-time market data.
ULGX last closed at USD 0; the session ranged USD 0–0 on volume of 125 shares. Market capitalization is $2,181, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, June 10, 2026 at 07:13 UTC.
Key Statistics (as of June 10, 2026 at 07:13 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 125 shares |
| Market Cap | $2,181 |
| Exchange | PNK |
Technical Analysis (ULGX)
Nexqual's technical model rates ULGX "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:13 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ULGX)
Wall Street analysts rate ULGX "None", per Nexqual as of June 10, 2026 at 07:13 UTC.
| Consensus Rating | None |
|---|
Earnings (ULGX)
Source: Nexqual, June 10, 2026 at 07:13 UTC.
Financials & Fundamentals (ULGX)
| Total Revenue | $12.00M |
|---|---|
| Revenue Growth (YoY) | -16.70% |
| Gross Margin | +47.13% |
| Operating Margin | -5.56% |
| Profit Margin | -38.90% |
| Current Ratio | 0.56 |
| Total Cash | $492,000 |
| Total Debt | $5.33M |
| Free Cash Flow | $725,875 |
Source: Nexqual, June 10, 2026 at 07:13 UTC.
Financial Health Score (ULGX)
Nexqual rates ULGX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:13 UTC.
| Growth | Strong — Revenue +15% YoY (annual) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $492K cash vs $5M debt |
| Cash Flow | Mixed — FCF $726K, slim 4.3% margin |
| Efficiency | Mixed — No data |
Ownership (ULGX)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 21.82M |
| Short % of Float | +0.30% |
Source: Nexqual, June 10, 2026 at 07:13 UTC.
Leadership (ULGX)
ULGX is led by Bryon Merade, Chairman & CEO, per Nexqual as of June 10, 2026 at 07:13 UTC.
| Chairman & CEO | Bryon Merade |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ESMC | Escalon Medical Corp. | USD 0.2 | ▲ 5.26% |
| IRIX | IRIDEX Corporation | USD 1.12 | ▲ 2.75% |
| UTMD | Utah Medical Products, Inc. | USD 68.07 | ▲ 0.62% |
| UAHC | United American Healthcare Corp | USD 0.02 | ▼ 5% |
| ARTC | Art Technology Acquisition Corp | USD 9.92 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:13 UTC. This page is informational and not investment advice.